Experiment #1
Attempt #1
GOAL: Test the strength of L7ae
3 complete 7/14/14: Seed cells 22 complete 7/15/14: Transfect MAV1212-hEF1a-eBFP2 (1084.0 ng/uL), Mutant hEF1a-2xKturn-eGFP (551.4 ng/uL) and Wild Type hEF1a-2xKturn-eGFP (287.0 ng/uL) into HEK cells 0 complete 7/17/14 (12 pm): Flow Cytometer
DNA Dilution: 5 uL MAV1212-hEF1a-eBFP2, 10 uL Mutant Hef1a-2xKturn-eGFP, 20 uL Wild Type Hef1a-2xKturn-eGFP
24-WELL PLATE TRANSFECTION MAP:
(B)1
(B)2
////// ////// ////// ////// (GM )1
Mutant Hef1a-2xKturn-eGFP (GM )2
Mutant Hef1a-2xKturn-eGFP (GM + B)1
Mutant Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GM + B)2
Mutant Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GM + B + L)1
Mutant Hef1a-2xKturn-eGFP Wild Type Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GM + B + L)2
Mutant Hef1a-2xKturn-eGFP Wild Type Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GWT )1
Wild Type Hef1a-2xKturn-eGFP (GWT )2
Wild Type Hef1a-2xKturn-eGFP
(GWT + B)1
Wild Type Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GWT + B)2
Wild Type Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GWT + B + L)1
Wild Type Hef1a-2xKturn-eGFP Mutant Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GWT + B + L)2
Wild Type Hef1a-2xKturn-eGFP Mutant Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 Neg Ctrl
Dummy DNA With Lipofectamine
Neg Ctrl
Dummy DNA With Lipofectamine
Neg/Neg Ctrl
Neg/Neg Ctrl
////// //////
RESULT: Transfection efficiency ~35%. FACS data is available
Attempt #2
2 complete 7/16/14: Seed cells 1 complete 7/17/14: Transfect MAV1212-hEF1a-eBFP2 (1084.0 ng/uL), Mutant hEF1a-2xKturn-eGFP (551.4 ng/uL) and Wild Type hEF1a-2xKturn-eGFP (287.0 ng/uL), MAV1212-hEF1a-L7ae (1686.4 ng/uL) into HEK cells 7 complete 7/19/14 (10 am): Flow Cytometer
DNA Dilution: 5 uL MAV1212-hEF1a-eBFP2, 10 uL Mutant Hef1a-2xKturn-eGFP, 20 uL Wild Type Hef1a-2xKturn-eGFP, 3 uL MAV1212-hEF1a-L7ae 24-WELL PLATE TRANSFECTION MAP:
(B)1
(B)2
////// ////// ////// ////// (GM )1
Mutant Hef1a-2xKturn-eGFP (GM )2
Mutant Hef1a-2xKturn-eGFP (GM + B)1
Mutant Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GM + B)2
Mutant Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GM + B + L)1
Mutant Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 MAV1212-hEF1a-L7ae (GM + B + L)2
Mutant Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 MAV1212-hEFa-L7ae (GWT )1
Wild Type Hef1a-2xKturn-eGFP (GWT )2
Wild Type Hef1a-2xKturn-eGFP
(GWT + B)1
Wild Type Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GWT + B)2
Wild Type Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 (GWT + B + L)1
Wild Type Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 MAV1212-hEFa1-L7ae (GWT + B + L)2
Wild Type Hef1a-2xKturn-eGFP MAV1212-hEF1a-eBFP2 MAV1212-hEF1a-L7ae Neg Ctrl
Dummy DNA With Lipofectamine
Neg Ctrl
Dummy DNA With Lipofectamine
Neg/Neg Ctrl
Neg/Neg Ctrl
////// //////
RESULT: Transfection efficiency ~35%. FACS data is available
Attempt #3
17 complete 7/24/14: Seed cells 18 complete 7/25/14: Transfect MAV1212-hEF1a-eBFP2, Mutant hEF1a-2xKturn-eGFP, Wild Type hEF1a-2xKturn-eGFP, MAV1212-hEF1a-L7ae, hEF1a-PirB (dummy DNA) all at ~500 ng/uL into HEK cells 19 complete 7/27/14 (10 am): Flow Cytometry DNA Dilution: MAV1212-hEF1a-eBFP2 (0.47 uL), Wild Type CAG-2xKturn-eGFP (0.96 uL), Mutant CAG-2xKturn-eGFP (0.96 uL), MAV1212-hEF1a-L7ae (0.71 uL), hEF1a-PirB (to 1 ug) 24-WELL PLATE TRANSFECTION MAP:
1. (B)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
hEF1a-PirB (1.5 fmole = 1.60 uL)
2. (B)2
MAV1212-hEF1a-eBFP2 (1.0 fmole)
hEF1a-PirB (1.5 fmole = 1.60 uL)
////// ////// ////// ////// 3. (GWT + B)2
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
hEF1a-PirB (1.0 fmole = 0.99 uL)
4. (GWT + B)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
hEF1a-PirB (1.0 fmole = 0.99 uL)
5. (GWT + B + L)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
6. (GWT + B + L)2
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
////// ////// 7. (GM + B)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Multant CAG-2xKturn-eGFP (1.5 fmoles)
hEF1a-PirB (1.0 fmole = 0.99 uL)
8. (GM + B)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Multant CAG-2xKturn-eGFP (1.5 fmoles)
hEF1a-PirB (1.0 fmole = 0.99 uL)
9. (GM + B + L)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Multant CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
10. (GM + B + L)2
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Multant CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
////// ////// 11. Neg Ctrl
hEF1a-PirB (3.2 fmoles = 2.05 uL)
With Lipofectamine
12. Neg Ctrl
hEF1a-PirB (3.2 fmoles = 2.05 uL)
With Lipofectamine
13. Neg/Neg Ctrl
No DNA
No Lipofectamine
14. Neg/Neg Ctrl
No DNA
No Lipofectamine
////// //////
RESULT: Transfection efficiency ___%. FACS data is available
Experiment #2
GOAL: Test the strength of TAL14
14 complete 7/25/14: Seed cells 15 complete 7/26/14: Transfect MAV1212-hEF1a-eBFP2 , TAL14-mKate , hEF1a-GAL4VP16 , hEF1a-TAL14, and hEF1a-PirB (dummy DNA) at ~500 ng/uL into HEK cells 16 incomplete 7/28/14 (4 pm): Flow Cytometry
DNA Dilution: MAV1212-hEF1a-eBFP2 (0.47 uL), TAL14-mKate (0.62 uL), hEF1a-GAL4VP16 (0.72 uL), hEF1a-TAL14 (___ uL), Dummy DNA (to 1 ug)
24-WELL PLATE TRANSFECTION MAP:
1. (B)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Dummy DNA (2.5 fmoles = 0.76 uL)
2. (B)2
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Dummy DNA (2.5 fmoles = 0.76 uL)
////// ////// //////
3. Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
4. (B + R)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
Dummy DNA (2.0 fmoles = 0.61 uL)
5. (B + R)2
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
Dummy DNA (2.0 fmoles = 0.61 uL)
//////
////// ////// 6. Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
7. (B + R + GAL)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
8. (B + R + GAL)2
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
//////
//////
////// 9. Neg/Neg Ctrl
No DNA
No Lipofectamine
10. (B + R + GAL)1
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
hEF1a-TAL14 (1.5 fmoles)
11. (B + R + GAL)2
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
hEF1a-TAL14 (1.5 fmoles)
//////
////// ////// 12. Neg/Neg Ctrl No DNA
No Lipofectamine
Experiment #3
GOAL: Test the sensors in absence of siRNA
10 complete incomplete 7/26/14: Seed cells 11 incomplete 7/27/14: Transfect Low Sensor miR-144 (708.2 ng/uL), Low Sensor miR-181c (628.1 ng/uL), High Sensor miR-30d (1046.2 ng/uL), High Sensor miR-146a (828.8 ng/uL), High Sensor 125b (1159.5 ng/uL) and High Sensor let-7f (889.6 ng/uL) into HEK cells 12 incomplete 7/29/14: (4 pm): Flow Cytometer
DNA Dilution: Low Sensor miR-144 (___ uL), Low Sensor miR-181c (___ uL), High Sensor miR-30d (___ uL) , High Sensor miR-146a (___ uL), High Sensor 125b (___ uL), High Sensor let-7f (___ uL)
24-WELL PLATE TRANSFECTION MAP:
1. miR-144
Low Sensor miR-144 ()
2. miR-181c
Low Sensor miR-181c (1.5 fmoles)
3. miR-30d
High Sensor miR-30d (1.5 fmoles)
4. miR-146a
High Sensor miR-146a (1.5 fmoles)
5. miR-125b
High Sensor miR-125b (1.5 fmoles)
6. let-7f
High Sensor let-7f (1.5 fmoles)
7. miR-144
Low Sensor miR-144 (1.5 fmoles)
8. miR-181c
Low Sensor miR-181c (1.5 fmoles)
9. miR-30d
High Sensor miR-30d (1.5 fmoles)
10. miR-146a
High Sensor miR-146a (1.5 fmoles)
11. miR-125b
High Sensor miR-125b (1.5 fmoles)
12. let-7f
High Sensor let-7f (1.5 fmoles)
//////
//////
////// ////// ////// ////// Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
Neg/Neg Ctrl
No DNA
No Lipofectamine
Neg/Neg Ctrl
No DNA
No Lipofectamine
//////
//////
RESULT: Brief description of experimental outcome (mean transfection efficiency and implications). Link to results page with data analysis.
Experiment #4
GOAL: Test the sensors in the presence of siRNA
13 complete Day 1: Seed cells 9 incomplete Day 2: Transfect Low Sensor miR-144 (708.2 ng/uL), Low Sensor miR-181c (628.1 ng/uL), High Sensor miR-30d (1046.2 ng/uL), High Sensor miR-146a (828.8 ng/uL), High Sensor 125b (1159.5 ng/uL), High Sensor let-7f (889.6 ng/uL), Mature 144 (___ ng/uL), Mature 181c (___ ng/uL), Mature 30d (___ ng/uL), Mature 146a (___ ng/uL), Mature 125b (___ ng/uL) and Mature let-7f (___ ng/uL) into HEK cells 20 incomplete Day 4: (2 pm): Flow Cytometer
DNA Dilution: ___ uL Low Sensor miR-144, ___ uL Low Sensor miR-181c, ___ uL High Sensor miR-30d, ___ uL High Sensor miR-146a, ___ uL High Sensor 125b, ___ uL High Sensor let-7f , ___ uL Mature 144, ___ uL Mature 181c, ___ uL Mature 30d, ___ uL Mature 146a, ___ uL Mature 125b and ___ uL Mature let-7f
24-WELL PLATE TRANSFECTION MAP:
144
Low Sensor miR-144 Mature 144
Low Sensor miR-181c Mature 181c
High Sensor miR-30d Mature 30d
High Sensor miR-146a Mature 146a
High Sensor miR-125b Mature 125b
High Sensor let-7f Mature let-7f
Low Sensor miR-144 Mature 144
Low Sensor miR-181c Mature 181c
High Sensor miR-30d Mature 30d
High Sensor miR-146a Mature 146a
High Sensor miR-125b Mature 125b
High Sensor let-7f Mature let-7f //////
//////
////// ////// ////// ////// Neg Ctrl
Dummy DNA With Lipofectamine
Neg Ctrl
Dummy DNA With Lipofectamine
Neg/Neg Ctrl
Neg/Neg Ctrl
//////
//////
RESULT: Brief description of experimental outcome (mean transfection efficiency and implications). Link to results page with data analysis.